Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
April 18, 2014
New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease
Beatriz López-Iglesias, Concepción Pérez, José A Morales-García, et al.
European Journal of Medicinal Chemistry
|
July 1, 2011
Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives
Daniel Silva, Mourad Chioua, Abdelouahid Samadi, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives
Cristóbal de Los Ríos, Javier Egea, José Marco-Contelles, et al.
ACS Chemical Neuroscience
|
July 11, 2014
ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease
Alejandro Romero, Javier Egea, Gema C González-Muñoz, et al.
Bioorganic & Medicinal Chemistry
|
December 31, 2010
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia
Abdelouahid Samadi, Elena Soriano, Julia Revuelta, et al.
Bioorganic & Medicinal Chemistry
|
July 27, 2010
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Abdelouahid Samadi, José Marco-Contelles, Elena Soriano, et al.
ACS Chemical Neuroscience
|
June 15, 2013
PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice
Silvia Lorrio, Alejandro Romero, Laura González-Lafuente, et al.
Chemmedchem
|
March 25, 2009
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties
María Isabel Fernández-Bachiller, Concepción Pérez, Nuria Eugenia Campillo, et al.
Neuropharmacology
|
December 12, 2012
Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia
Silvia Lorrio, Vanessa Gómez-Rangel, Pilar Negredo, et al.
Bioorganic & Medicinal Chemistry
|
December 18, 2010
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Abdelouahid Samadi, Carolina Valderas, Cristóbal de los Ríos, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
April 18, 2014
New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease
Beatriz López-Iglesias, Concepción Pérez, José A Morales-García, et al.
European Journal of Medicinal Chemistry
|
July 1, 2011
Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives
Daniel Silva, Mourad Chioua, Abdelouahid Samadi, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives
Cristóbal de Los Ríos, Javier Egea, José Marco-Contelles, et al.
ACS Chemical Neuroscience
|
July 11, 2014
ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease
Alejandro Romero, Javier Egea, Gema C González-Muñoz, et al.
Bioorganic & Medicinal Chemistry
|
December 31, 2010
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia
Abdelouahid Samadi, Elena Soriano, Julia Revuelta, et al.
Bioorganic & Medicinal Chemistry
|
July 27, 2010
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Abdelouahid Samadi, José Marco-Contelles, Elena Soriano, et al.
ACS Chemical Neuroscience
|
June 15, 2013
PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice
Silvia Lorrio, Alejandro Romero, Laura González-Lafuente, et al.
Chemmedchem
|
March 25, 2009
Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties
María Isabel Fernández-Bachiller, Concepción Pérez, Nuria Eugenia Campillo, et al.
Neuropharmacology
|
December 12, 2012
Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia
Silvia Lorrio, Vanessa Gómez-Rangel, Pilar Negredo, et al.
Bioorganic & Medicinal Chemistry
|
December 18, 2010
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Abdelouahid Samadi, Carolina Valderas, Cristóbal de los Ríos, et al.
Page
of 5